These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 16430799)

  • 21. Effect of aprotinin (trasylol) on the inflammatory and thrombotic complications of conventional cardiopulmonary bypass surgery.
    Landis RC; Asimakopoulos G; Poullis M; Thompson R; Nourshargh S; Haskard DO; Taylor KM
    Heart Surg Forum; 2001; 4 Suppl 1():S35-9. PubMed ID: 11178306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aprotinin and the risk of death and renal dysfunction in patients undergoing cardiac surgery: a meta-analysis of epidemiologic studies.
    Gagne JJ; Griesdale DE; Schneeweiss S
    Pharmacoepidemiol Drug Saf; 2009 Apr; 18(4):259-68. PubMed ID: 19185048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pro: Aprotinin has a good efficacy and safety profile relative to other alternatives for prevention of bleeding in cardiac surgery.
    Body SC; Mazer CD
    Anesth Analg; 2006 Dec; 103(6):1354-9. PubMed ID: 17122202
    [No Abstract]   [Full Text] [Related]  

  • 24. A randomized, controlled trial of aprotinin in neonates undergoing open-heart surgery.
    Williams GD; Ramamoorthy C; Pentcheva K; Boltz MG; Kamra K; Reddy VM
    Paediatr Anaesth; 2008 Sep; 18(9):812-9. PubMed ID: 18768040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The association of renal dysfunction and the use of aprotinin in patients undergoing congenital cardiac surgery requiring cardiopulmonary bypass.
    Manrique A; Jooste EH; Kuch BA; Lichtenstein SE; Morell V; Munoz R; Ellis D; Davis PJ
    Anesth Analg; 2009 Jul; 109(1):45-52. PubMed ID: 19535694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Commentary on the article of Dennis T. Mangano: Aprotinin and risks in cardiac surgery].
    Bizouarn P
    Ann Fr Anesth Reanim; 2006 Jul; 25(7):791-5. PubMed ID: 16839738
    [No Abstract]   [Full Text] [Related]  

  • 27. Aprotinin is useful as a hemostatic agent in cardiopulmonary surgery: no.
    Karkouti K; Beattie WS
    J Thromb Haemost; 2006 Sep; 4(9):1879-81. PubMed ID: 16803464
    [No Abstract]   [Full Text] [Related]  

  • 28. Pulmonary vascular resistance index during coronary artery bypass surgery with aprotinin.
    Toikkanen V; Rinne T; Laurikka J; Porkkala H; Tarkka M; Mennander A
    Scand J Clin Lab Invest; 2017 Sep; 77(5):315-320. PubMed ID: 28460544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aprotinin is useful as a hemostatic agent in cardiopulmonary surgery: yes.
    Levy JH
    J Thromb Haemost; 2006 Sep; 4(9):1875-8. PubMed ID: 16805858
    [No Abstract]   [Full Text] [Related]  

  • 30. Aprotinin and cardiac surgery.
    DeAnda A
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):492-4. PubMed ID: 18329458
    [No Abstract]   [Full Text] [Related]  

  • 31. [Aprotinin in cardiac surgery: one paper of the year or a provocation from the New England Journal of Medicine].
    Blanloeil Y
    Ann Fr Anesth Reanim; 2006 Jul; 25(7):683-5. PubMed ID: 16919751
    [No Abstract]   [Full Text] [Related]  

  • 32. Renal dysfunction in cardiac surgery: identifying potential risk factors.
    Barnum JL; Sistino JJ
    Perfusion; 2009 Mar; 24(2):139-42. PubMed ID: 19654159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cystatin C in cardiac surgery.
    Momeni M; Baele P; Jacquet L; Mourad M; Waterloos H; Wallemacq P
    Acta Anaesthesiol Belg; 2007; 58(2):107-12. PubMed ID: 17710898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Topical aprotinin in cardiac operations: a note of caution.
    Ciçek S; Theodoro DA
    Ann Thorac Surg; 1996 Mar; 61(3):1039-40. PubMed ID: 8619685
    [No Abstract]   [Full Text] [Related]  

  • 35. A propensity score case-control comparison of aprotinin and tranexamic acid in high-transfusion-risk cardiac surgery.
    Karkouti K; Beattie WS; Dattilo KM; McCluskey SA; Ghannam M; Hamdy A; Wijeysundera DN; Fedorko L; Yau TM
    Transfusion; 2006 Mar; 46(3):327-38. PubMed ID: 16533273
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aprotinin and microvascular thrombosis in cardiac surgery.
    Ranucci M
    Intensive Care Med; 2008 Jul; 34(7):1175-6. PubMed ID: 18301878
    [No Abstract]   [Full Text] [Related]  

  • 37. Brain natriuretic peptide in cardiac surgery--influence of aprotinin.
    Bail DH; Ziemer G
    Int J Cardiol; 2009 Aug; 136(2):227-8. PubMed ID: 18625528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Administration of aprotinin in surgical interventions associated with a high risk hemorrhagic complications].
    Charnaia MA; Dement'eva II
    Khirurgiia (Mosk); 2005; (11):71-6. PubMed ID: 16358454
    [No Abstract]   [Full Text] [Related]  

  • 39. The demise of aprotinin: our share of the blame.
    Sundt TM
    J Thorac Cardiovasc Surg; 2008 Apr; 135(4):729-31. PubMed ID: 18374748
    [No Abstract]   [Full Text] [Related]  

  • 40. Aprotinin is safe in pediatric patients undergoing cardiac surgery.
    Backer CL; Kelle AM; Stewart RD; Suresh SC; Ali FN; Cohn RA; Seshadri R; Mavroudis C
    J Thorac Cardiovasc Surg; 2007 Dec; 134(6):1421-6; discussion 1426-8. PubMed ID: 18023656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.